Drug
Contrave
Contrave: highest development phase Post-Market, developed by Bausch Health, United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bausch Health, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Contrave 8Mg-90Mg Extended-Release Tablet NCT04587843 | Post-Market | Obesity |
| Contrave NCT06809166 | Post-Market | Obesity |
Latest
No recent events.
Follow Contrave on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.